Product Details:
Alternate Name |
5-((7-Cl-1H-indol-3-yl)methyl)-3-methylimidazolidine-2,4-dione); 7-Cl-O-Nec-1 |
Peptide Sequence |
No |
Appearance |
Yellow solid |
CAS # |
852391-15-2 |
Molecular Formula |
C₁₃H₁₂ClN₃O₂ |
Molecular Weight |
277.71 |
Purity |
≥96% by TLC and LC-MS |
Solubility |
DMSO |
SMILES |
CN1C(=O)C(NC1=O)CC2=CNC3=C2C=CC=C3Cl |
InChi |
InChI=1S/C13H12ClN3O2/c1-17-12(18)10(16-13(17)19)5-7-6-15-11-8(7)3-2-4-9(11)14/h2-4,6,10,15H,5H2,1H3,(H,16,19) |
InChi Key |
WIKGAEMMNQTUGL-UHFFFAOYSA-N |
PubChem CID |
643953 |
Handling |
Protect from light and moisture |
Storage Conditions |
-20°C |
Shipping Conditions |
Gel Pack |
USAGE |
For Research Use Only! Not For Use in Humans. |

biovision nec 1s
Descriptions:
A potent necroptosis inhibitor. Displays higher activity in inhibiting necroptosis in Jurkat cells than Nec-1 (Cat. No. 1864) (EC₅₀ = 210 nM versus EC₅₀ = 490 nM), as well as showing no nonspecific cytotoxicity at high concentrations (~100 mM). More useful for in-cell and in vivo experiments compared to Nec-1.
Abstract
Abdominal aortic aneurysm (AAA) is a common aortic disease with a progressive nature. There is no approved pharmacological treatment that would effectively slow the growth of the aneurysm or prevent rupture. Necrosis is a form of programmed necrosis that is regulated by receptor-interacting protein kinases (RIPs). We have recently shown that a lack of RIP3 in mice prevented aneurysm formation.
The aim of this study is to test whether disruptive necrosis affects the progression of existing aneurysms using RIP1 inhibitors Necrostatin-1 (Nec-1) and optimized forms of Nec-1, 7-Cl-O-Nec-1 (Nec-1 s). Seven days after induction of the aneurysm by elastase perfusion, mice were randomly administered DMSO, Nec-1 (3.2 mg / kg / day) and Nec-1s (1.6 mg / kg / day) by intraperitoneal injection. After sacrifice on day 14 of postaneurysm induction, the aortic expansion in the Nec-1s group (64.12 ± 4.80%) was significantly smaller than in the DMSO group (172.80 ± 13.68%) (P <0.05).
The mean aortic diameter of Nec-1-treated mice appeared to be smaller (121.60 ± 10.40%) than the DMSO group, although the difference was not statistically significant (P = 0.1). Histologically, the aortic structure of Nec-1s-treated mice appeared normal, with continuous and organized elastin layers and rich SMCs expressing αActin. In addition, Nect-1 treatment reduced macrophage infiltration and MMP9 accumulation and increased tropoelastin and lysyl oxidase aortic levels. Together, our data suggest that pharmacological inhibition of necrosis by Nec-1 stabilizes pre-existing aneurysms by reducing inflammation and promoting connective tissue repair.
EZSolution? Nec-1s |
2535-1 |
Biovision |
each |
EUR 151.2 |
Growth Medium 1S |
78221 |
BPS Bioscience |
500 ml |
EUR 650 |
Description: This liquid Growth Medium is a complete medium optimized to culture select BPS Bioscience cell lines.Optimized for Use With: CRISPRa (SAM) HeLa Cell Line (BPS Bioscience, #78193), CRISPRa (SAM) HepG2 Cell Line (BPS Bioscience, #78194) |
(1S,3R)-ACPD |
B6245-10 |
ApexBio |
10 mg |
EUR 564 |
(1S,3R)-ACPD |
B6245-50 |
ApexBio |
50 mg |
EUR 2182.8 |
(1S)-(-)-α-Pinene |
C7097-100 |
ApexBio |
100mg |
EUR 40 |
|
(1S)-(-)-α-Pinene |
C7097-200 |
ApexBio |
200mg |
EUR 50 |
|
(1S)-(-)-alpha-Pinene |
TBW01089 |
ChemNorm |
0.1mL |
Ask for price |
(1S,3R)-3-aminocyclohexanol |
20-abx184839 |
Abbexa |
|
|
|
(1S,3S)-3-Aminocyclohexanol |
20-abx184840 |
Abbexa |
|
|
|
Milnacipran ((1S-cis) hydrochloride) |
HY-B0168B |
MedChemExpress |
5mg |
EUR 224.4 |
NPEC-caged-(1S,3R)-ACPD |
B7369-10 |
ApexBio |
10 mg |
EUR 661.2 |
NPEC-caged-(1S,3R)-ACPD |
B7369-50 |
ApexBio |
50 mg |
EUR 2590.8 |
(1S,3R,5R)-PIM447 (dihydrochloride) |
HY-19322C |
MedChemExpress |
50mg |
EUR 2539.2 |
cis-(1S,2R)-2-Aminocyclopentanol hydrochloride |
20-abx182399 |
Abbexa |
-
EUR 594.00
-
EUR 3951.60
-
EUR 1395.60
|
|
|
Microtubule Associated Protein 1S (MAP1S) Antibody |
abx234975-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
Tert-Butyl (1S,3R)-3-Hydroxycyclopentylcarbamate |
20-abx185572 |
Abbexa |
-
EUR 678.00
-
EUR 393.60
-
EUR 1612.80
|
|
|
(1S,3S)-Methyl 3-aminocyclopentanecarboxylate hydrochloride |
abx186027-1g |
Abbexa |
1 g |
EUR 3316.8 |
|
Microtubule Associated Protein 1S (MAP1S) Antibody |
20-abx109998 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
(1S,2R)-2-(Boc-amino)cyclopentanecarboxylicacid |
20-abx180085 |
Abbexa |
-
EUR 427.20
-
EUR 2380.80
-
EUR 927.60
|
|
|
Microtubule-associated protein 1S Polyclonal Antibody |
42570-100ul |
SAB |
100ul |
EUR 399.6 |
Microtubule Associated Protein 1S (MAP1S) Antibody |
20-abx113745 |
Abbexa |
|
|
|
Microtubule Associated Protein 1S (MAP1S) Antibody |
abx032611-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Microtubule Associated Protein 1S (MAP1S) Antibody |
abx032611-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Microtubule Associated Protein 1S (MAP1S) Antibody |
20-abx002312 |
Abbexa |
|
|
|
Human Microtubule-associated protein 1S (MAP1S) |
1-CSB-RP135494h |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
Description: Recombinant Human Microtubule-associated protein 1S(MAP1S),partial expressed in E.coli |
Microtubule Associated Protein 1S (MAP1S) Antibody |
abx145490-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
Recombinant Microtubule Associated Protein 1S (MAP1S) |
RPU58260-100ug |
Biomatik Corporation |
100ug |
EUR 537.6 |
Recombinant Microtubule Associated Protein 1S (MAP1S) |
RPU58260-1mg |
Biomatik Corporation |
1mg |
EUR 2496 |
Recombinant Microtubule Associated Protein 1S (MAP1S) |
RPU58260-50ug |
Biomatik Corporation |
50ug |
EUR 418 |